Depakote levels should be checked after every dose change, then every 3 to 6 months once you’re on a stable dose. The exact schedule depends on where you are in treatment: just starting, adjusting, or maintaining a long-term regimen. Getting the timing and frequency right matters because Depakote has a relatively narrow therapeutic range, and levels that drift too high or too low can cause problems.
When to Check After Starting or Changing a Dose
Depakote reaches a stable concentration in your blood after about 4 days of consistent dosing. Any blood draw before that point won’t reflect your true level, so there’s no reason to test sooner unless toxicity is suspected. After starting the medication or adjusting your dose, your provider will typically order a level once that 4-day window has passed.
If the result comes back outside the target range, your dose gets adjusted and the clock resets: another 4 days to stabilize, then another blood draw. This cycle repeats until your level lands in the right zone. For epilepsy, the target is 50 to 100 mcg/mL. For bipolar mania, it’s slightly wider at 50 to 125 mcg/mL.
How Often on a Stable Dose
Once your levels are in range and your symptoms are well controlled, routine monitoring shifts to every 3 to 6 months. These checks include not just the drug level itself but also liver function tests and a complete blood count. Depakote can affect liver enzymes and platelet counts over time, so these labs are drawn together as a package.
During the first six months of treatment, liver monitoring should happen more frequently. The FDA labeling specifically calls for liver tests “at frequent intervals” in this early window because the risk of liver injury is highest when the medication is new. After that initial period, the standard 3-to-6-month rhythm is typical for most adults.
Getting an Accurate Blood Draw
The timing of your blood draw relative to your last dose has a significant effect on the result. Depakote levels are measured as “trough” levels, meaning the lowest point in the dosing cycle, which is right before your next dose.
If you take the extended-release version once daily in the morning, a blood sample drawn 21 to 24 hours after your dose will land within about 3% of the true trough value. But if blood is drawn only 12 to 15 hours after your dose, the reading can come back 18 to 25% higher than the actual trough. That difference could make your level look like it’s at the upper edge of the range when it’s actually fine, potentially leading to an unnecessary dose reduction.
If your lab appointment can’t be scheduled right before your next dose, your provider can adjust the number. A level drawn at 12 hours can be divided by roughly 1.3 to estimate the true trough. But the simplest approach is to schedule your blood draw in the morning before you take that day’s dose.
Situations That Trigger Extra Checks
Several situations call for a level check outside the routine schedule:
- Adding or stopping another medication. Many drugs affect how your body processes Depakote. When a new medication enters the picture or an existing one is discontinued, your Depakote level can shift even though your dose hasn’t changed. A recheck after 4 to 5 days on the new regimen confirms you’re still in range.
- Breakthrough symptoms. If seizures return or mood symptoms flare despite consistent dosing, a level check helps determine whether the medication has dropped below the therapeutic floor.
- Signs of toxicity. Tremors, unusual drowsiness, confusion, vomiting, diarrhea, or abdominal pain can signal that levels have climbed too high. In suspected toxicity, levels may be drawn every 2 to 4 hours until the concentration starts declining.
- Significant weight change. Depakote dosing is weight-sensitive. A large gain or loss can shift your blood concentration enough to warrant rechecking.
Monitoring in Children
Children under 10 clear Depakote from their bodies about 50% faster per kilogram of body weight than adults do. This faster metabolism means pediatric levels can fluctuate more, and dose adjustments may be needed more often. Children under two face the highest risk of serious liver problems, particularly those taking multiple seizure medications or those with certain metabolic or neurological conditions. For this age group, liver function tests are checked especially frequently, and the medication is used only as a last resort.
Monitoring During Pregnancy
Pregnancy changes how the body handles many medications, and Depakote is no exception. Blood volume increases, protein binding shifts, and kidney filtration speeds up, all of which can lower drug levels even on the same dose. For pregnant patients with epilepsy whose seizures are stable, a minimum of three monitoring visits during pregnancy is recommended, with more frequent checks if seizures break through or levels drop. In the first week after delivery, a level should be rechecked because those pregnancy-related changes reverse quickly, and a dose that was appropriate during the third trimester may suddenly be too high.
What the Numbers Mean in Practice
The therapeutic range isn’t a hard cutoff. Some people do well at the lower end, and others need levels closer to the ceiling. The range of 50 to 100 mcg/mL for epilepsy and 50 to 125 mcg/mL for mania is a guideline, not a guarantee. If your symptoms are controlled and you’re not experiencing side effects, a level slightly outside the textbook range doesn’t automatically mean a dose change is needed. Conversely, a level that looks “normal” on paper doesn’t rule out problems if you’re having symptoms.
For absence seizures specifically, the correlation between blood levels and symptom control is weaker than for other seizure types. Your clinical response matters as much as the number on the lab report. That said, keeping levels within the accepted range provides a safety margin against toxicity while maximizing the chance of good symptom control.